Market Overview:
The global ofloxacin market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of infectious diseases, rising demand for ofloxacin in emerging markets, and growing number of approvals for ofloxacin by regulatory authorities. Based on type, the global ofloxacin market can be segmented into oral, intravenous therapy (IV), and topical (eye drops & ear drops). The oral segment is expected to account for the largest share of the global market in 2018. This segment is projected to grow at a CAGR of XX% during the forecast period. The IV segment is projected to grow at a CAGR of XX% during the forecast period. This growth can be attributed to rising demand for IV formulations due to their high efficacy and safety profile as compared with other formulations. Based on application, hospital pharmacies accounted for the largest share of the global market in 2017 and this trend is expected continue duringthe forecast period from 2018-2030 .
Product Definition:
Ofloxacin is a synthetic chemotherapeutic agent classified as a fluoroquinolone antibiotic. It is used to treat bacterial infections, including pneumonia, bronchitis, and sinus infections.
Oral:
Oral is a route of administration which involves the use of drugs in the form of tablets, capsules or liquids directly into the mouth. The oral drug absorption process is usually easy and quick as compared to injectable and pulmonary routes. Due to this reason, it’s one of the most preferred routes for drug delivery among patients as well as healthcare professionals.
The factors that propel growth factor in oral route are ease in administration, rapid onset action.
Intravenous Therapy (IV):
Intravenous therapy (IV) is the delivery of medications by IV infusion. The process allows for the administration of large volumes of liquid medication at a time, which may be more convenient and efficient than oral medications. Intravenous therapy has several advantages such as it allows drugs to be administered that would otherwise not be possible or practical with oral methods, it offers higher drug concentrations when compared to oral dosage forms and lastly, it's cost-effective in nature.
Application Insights:
Based on the application, the global market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. The hospital pharmacy segment dominated the overall industry in terms of revenue in 2017. This can be attributed to factors such as a high usage rate for Ofloxacin and presence of a large number of hospitals that cater to a wide range of patient demographics thereby increasing demand for pharmaceutical products including Ofloxacin.
The IV antibiotic therapy was one of the most commonly used forms across all regions with respect to outpatient settings and accounted for over 40% among hospitalized patients globally.
Regional Analysis:
North America was the largest regional market in 2017 owing to high awareness levels and presence of key manufacturers. The region is expected to maintain its dominance over the forecast period due to increasing number of generic product launches. Asia Pacific is estimated to be the fastest-growing region during the forecast years on account of rising geriatric population base, which is more prone to infections and diseases, growing healthcare expenditure by governments as well as individuals, and availability of effective treatment methods through private sector pharmacies at affordable prices. In addition, rise in disposable income levels will boost demand for medicines among all age groups in developing countries such as China & India thereby driving overall growth across this region.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the major growth drivers for the global ofloxacin market. Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, and parasites. They can cause a wide range of illnesses in humans ranging from mild to life-threatening conditions. The increasing incidence of infectious diseases is mainly due to the changing lifestyle and environmental factors, growing population, and globalization. This is expected to drive the demand for ofloxacin globally in the coming years.
- Rising prevalence of antibiotic resistance: The rising prevalence of antibiotic resistance is another key factor that is expected to fuel the growth of the global ofloxacin market in future years. Antibiotic resistance occurs when bacteria develop immunity against antibiotics, making them ineffective against infections caused by these bacteria strains. This has become a major public health concern across the world as it leads to increased mortality rates and healthcare costs due to untreatable infections caused by resistant strainsof bacteria .The increasing prevalenceof antibioticresistanceisexpectedtodrivethedemandforofloxacingloballyinthecomingyears
Scope Of The Report
Report Attributes
Report Details
Report Title
Ofloxacin Market Research Report
By Type
Oral, Intravenous Therapy (IV), Topical (Eye Drops & Ear Drops)
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Novartis, Teva, Allergan, Apotex, Janssen, Daiichi Sankyo, Cadila Pharmaceuticals, Bestochem, Almatica Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Ofloxacin Market Report Segments:
The global Ofloxacin market is segmented on the basis of:
Types
Oral, Intravenous Therapy (IV), Topical (Eye Drops & Ear Drops)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Teva
- Allergan
- Apotex
- Janssen
- Daiichi Sankyo
- Cadila Pharmaceuticals
- Bestochem
- Almatica Pharma
Highlights of The Ofloxacin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Intravenous Therapy (IV)
- Topical (Eye Drops & Ear Drops)
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ofloxacin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ofloxacin is a fluoroquinolone antibiotic. It works by killing bacteria.
Some of the major companies in the ofloxacin market are Novartis, Teva, Allergan, Apotex, Janssen, Daiichi Sankyo, Cadila Pharmaceuticals, Bestochem, Almatica Pharma.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Ofloxacin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Ofloxacin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Ofloxacin Market - Supply Chain
4.5. Global Ofloxacin Market Forecast
4.5.1. Ofloxacin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Ofloxacin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Ofloxacin Market Absolute $ Opportunity
5. Global Ofloxacin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Ofloxacin Market Size and Volume Forecast by Type
5.3.1. Oral
5.3.2. Intravenous Therapy (IV)
5.3.3. Topical (Eye Drops & Ear Drops)
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Ofloxacin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Ofloxacin Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Ofloxacin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Ofloxacin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Ofloxacin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Ofloxacin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Ofloxacin Demand Share Forecast, 2019-2026
9. North America Ofloxacin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Ofloxacin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Ofloxacin Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Ofloxacin Market Size and Volume Forecast by Type
9.7.1. Oral
9.7.2. Intravenous Therapy (IV)
9.7.3. Topical (Eye Drops & Ear Drops)
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Ofloxacin Demand Share Forecast, 2019-2026
10. Latin America Ofloxacin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Ofloxacin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Ofloxacin Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Ofloxacin Market Size and Volume Forecast by Type
10.7.1. Oral
10.7.2. Intravenous Therapy (IV)
10.7.3. Topical (Eye Drops & Ear Drops)
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Ofloxacin Demand Share Forecast, 2019-2026
11. Europe Ofloxacin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Ofloxacin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Ofloxacin Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Ofloxacin Market Size and Volume Forecast by Type
11.7.1. Oral
11.7.2. Intravenous Therapy (IV)
11.7.3. Topical (Eye Drops & Ear Drops)
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveess/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Ofloxacin Demand Share, 2019-2026
12. Asia Pacific Ofloxacin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Ofloxacin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Ofloxacin Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Ofloxacin Market Size and Volume Forecast by Type
12.7.1. Oral
12.7.2. Intravenous Therapy (IV)
12.7.3. Topical (Eye Drops & Ear Drops)
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Ofloxacin Demand Share, 2019-2026
13. Middle East & Africa Ofloxacin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Ofloxacin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Ofloxacin Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Ofloxacin Market Size and Volume Forecast by Type
13.7.1. Oral
13.7.2. Intravenous Therapy (IV)
13.7.3. Topical (Eye Drops & Ear Drops)
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Ofloxacin Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Ofloxacin Market: Market Share Analysis
14.2. Ofloxacin Distributors and Customers
14.3. Ofloxacin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Novartis
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Teva
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Allergan
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Apotex
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Janssen
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Daiichi Sankyo
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Cadila Pharmaceuticals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Bestochem
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Almatica Pharma
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
